Steven Cohen's PRAX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 492,346 shares of Praxis Precision Medicines, Inc. (PRAX) worth $145.11 M, representing 0.16% of the portfolio. First purchased in 2020-Q4, this long-term strategic position has been held for 21 quarters.
Based on 13F filings, Steven Cohen has maintained a strategic position in PRAX, demonstrating sustained confidence in this investment. Largest addition occurred in Q2 2023, adding 700,000 shares. Largest reduction occurred in Q4 2025, reducing 1 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Praxis Precision Medicines (PRAX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Praxis Precision Medicines (PRAX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -1 M | Reduce 67.09% | 492,346 | $294.74 |
| Q3 2025 | +541,911 | Add 56.80% | 1.5 M | $53.00 |
| Q2 2025 | +620,541 | Add 186.05% | 954,075 | $42.05 |
| Q1 2025 | -187,739 | Reduce 36.02% | 333,534 | $37.87 |
| Q4 2024 | -511,971 | Reduce 49.55% | 521,273 | $76.96 |
| Q3 2024 | -18,457 | Reduce 1.75% | 1.03 M | $57.54 |
| Q2 2024 | +97,561 | Add 10.23% | 1.05 M | $41.36 |
| Q1 2024 | +261,888 | Add 37.83% | 954,140 | $61.02 |
| Q3 2023 | -11,081 | Reduce 1.58% | 692,252 | $25.65 |
| Q2 2023 | +700,000 | Add 21002.10% | 703,333 | $17.25 |
| Q1 2023 | -3,334 | Reduce 50.01% | 3,333 | $12.14 |
| Q2 2022 | -81,929 | Reduce 92.47% | 6,667 | $36.75 |
| Q1 2022 | -7,830 | Reduce 8.12% | 88,596 | $153.16 |
| Q4 2021 | +20,626 | Add 27.21% | 96,426 | $295.50 |
| Q3 2021 | +23,334 | Add 44.47% | 75,800 | $277.35 |
| Q2 2021 | +43,333 | Add 474.47% | 52,466 | $274.20 |
| Q1 2021 | -7,534 | Reduce 45.20% | 9,133 | $491.40 |
| Q4 2020 | +16,667 | New Buy | 16,667 | $825.28 |
Steven Cohen's Praxis Precision Medicines Investment FAQs
Steven Cohen first purchased Praxis Precision Medicines, Inc. (PRAX) in Q4 2020, acquiring 16,667 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Praxis Precision Medicines, Inc. (PRAX) for 21 quarters since Q4 2020.
Steven Cohen's largest addition to Praxis Precision Medicines, Inc. (PRAX) was in Q2 2023, adding 703,333 shares worth $12.13 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 492,346 shares of Praxis Precision Medicines, Inc. (PRAX), valued at approximately $145.11 M.
As of the Q4 2025 filing, Praxis Precision Medicines, Inc. (PRAX) represents approximately 0.16% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Praxis Precision Medicines, Inc. (PRAX) was 1,495,986 shares, as reported at the end of Q3 2025.